CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		166 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Cash flows from operating activities:
Net loss	$ (12,209,500)	$ (9,482,200)	$ (54,782,500)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	45,600	45,300	743,700
Amortization of discounts on 7%, 7.5% and 10% notes	57,200	71,000	259,200
Amortization of discounts on Platinum notes	909,000	1,376,600	3,548,700
Amortization of discounts on August 2010 short-term notes	14,300	557,700	572,000
Amortization of discounts on February 2012 12% convertible notes	(4,200)		(4,200)
Change in put and note term extension option and warrant liabilities	77,900	(203,900)	(418,600)
Fair value of Series C preferred stock, common stock, and warrants granted for services prior to the Merger	131,200		1,056,600
Stock-based compensation	1,591,300	1,628,800	4,354,300
Loss on early extinguishment of debt	1,193,500		1,193,500
Expense related to modification of warrants	741,700		741,700
Fair value of common stock granted for services following the Merger	452,000		452,000
Fair value of warrants granted for services following the Merger	564,500		564,500
Fair value of additional warrants granted under Discounted Warrant Exercise Program	138,100		138,100
Fair value of common stock issued for note term modification	22,400		22,400
Consulting services by related parties settled by issuing promissory notes			44,600
Acquired in-process research and development			7,523,200
Amortization of imputed discount on non-interest bearing notes			45,000
Gain on sale of assets			16,800
Changes in operating assets and liabilities:
Unbilled contract payments receivable	64,000	(205,000)	106,200
Prepaid expenses and other current assets	1,900	(630,900)	4,500
Security deposits and other assets	(2,100)	(4,500)	29,000
Accounts payable and accrued expenses	2,838,600	4,385,500	16,580,600
Deferred revenues.	(65,600)	(60,500)	13,200
Net cash used in operating activities	(3,565,800)	(841,300)	(17,508,500)
Cash flows from investing activities:
Purchases of equipment, net	(32,400)	(57,800)	(680,800)
Net cash used in investing activities	(32,400)	(57,800)	(680,800)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including units	2,679,200		2,800,000
Proceeds from exercise of warrants under Discounted Warrant Exercise Program	1,166,300		1,166,300
Net proceeds from issuance of preferred stock and warrants			4,198,600
Proceeds from issuance of notes under line of credit			200,000
Proceeds from issuance of 7% note payable to founding stockholder			90,000
Net proceeds from issuance of 7% convertible notes			575,000
Net proceeds from issuance of 10% convertible notes and warrants			1,655,000
Net proceeds from issuance of Platinum notes and warrants			3,700,000
Net proceeds from issuance of 2008/2010 notes and warrants		270,000	2,971,800
Net proceeds from issuance of 2006/2007 notes and warrants			1,025,000
Proceeds from issuance of 7% notes payable			55,000
Net proceeds from issuance of August 2010 short-term notes and warrants		800,000	800,000
Net proceeds from issuance of February 2012 12% convertible notes and warrants	466,500		466,500
Repayment of capital lease obligations	(14,500)	(27,000)	(100,500)
Repayment of notes	(757,600)	(205,600)	(1,332,400)
Net cash provided by financing activities	3,539,900	837,400	18,270,300
Net increase in cash and cash equivalents	(58,300)	(61,700)	81,000
Cash and cash equivalents at beginning of period	139,300	201,000
Cash and cash equivalents at end of period	81,000	139,300	81,000
Cash paid for interest	265,400	147,400	439,700
Cash paid for income taxes	1,600	1,600	16,800
Supplemental disclosure of noncash activities:
Forgiveness of accrued compensation and accrued interest payable to officers transferred to equity			800,000
Exercise of warrants and options in exchange for debt cancellation			112,800
Settlement of accrued and prepaid interest by issuance of Series C Preferred Stock			35,300
Conversion of 10% notes payable, net of discount, and related accrued interest into Series C Preferred stock			2,050,300
Issuance of Series B-1 Preferred stock for acquired in-process research and development			7,523,200
Conversion of 7% notes payable, net of discount, and related accrued interest into Series B Preferred stock			508,000
Conversion of accounts payable into convertible promissory notes			893,700
Conversion of accounts payable into note payable		1,126,200	2,810,300
Conversion of accounts payable into common stock	275,400		1,824,100
Conversion of accrued interest on convertible promissory notes into common stock			921,400
Notes receivable from sale of common stock to related parties upon exercise of options and warrants			149,800
Capital lease obligations	19,000		139,700
Recognition of put option and note term extension option liabilities upon issuance of Platinum Notes			141,200
Incremental fair value of put option and note term extension option liabilities from debt modifications		158,000	479,400
Incremental fair value of note conversion option from debt modification		1,062,800	1,891,200
Incremental fair value of warrant from debt modifications		121,100	276,700
Recognition of warrant liability upon adoption of new accounting standard			151,300
Fair value of warrants issued with August 2010 short term notes		130,900	130,900
Note Discount upon issuance of August 2010 short-term notes		320,000	320,000
Fair value of warrants issued with February 2012 12% convertible notes	542,000		542,000
Note Discount upon issuance of February 2012 12% convertible notes	$ 495,200		$ 495,200